Godrej Agrovet Limited · NSE:GODREJAGRO
Godrej Agrovet — Q4 FY2020 Earnings Presentation
20 slides from Godrej Agrovet's earnings presentation, May 11, 2020
Slide 1: Cover letter to stock exchanges: Presentation to Investors & Analysts
Date: May 11, 2020 To, To, BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, BandraKurla Complex, Mumbai – 400 001. Bandra (East), Mumbai - 400 051. Ref.: BSE Scrip Code No. “540743” Ref.: “GODREJAGRO” Subject: Presentation to Investors & Analysts
Slide 2: 4Q & FY20 Performance Update
4Q & FY20 PERFORMANCE UPDATE May 11, 2020
Slide 3: GAVL Performance Highlights
GAVL PERFORMANCE HIGHLIGHTS 2 I Godrej Agrovet
Slide 4: 4QFY20 Financials – Key Highlights
4QFY20 FINANCIALS – Key Highlights Particulars Standalone Consolidated (Rs crore, unless stated) 4QFY20 4QFY19 % Growth 4QFY20 4QFY19 % Growth Total Income 1,165.5 1,002.2 16.3% 1,643.6 1,401.6 17.3% Earnings before interest, tax and 127.6 48.5 163.2% 142.2 85.5 66.3% Depreciation (EBITDA) EBITDA Ma
Slide 5: FY20 Financials – Key Highlights
FY20 FINANCIALS – Key Highlights Particulars Standalone Consolidated (Rs crore, unless stated) FY20 FY19 % Growth FY20 FY19 % Growth Total Income 5,159.7 4,394.9 17.4% 7,010.9 5.970.8 17.4% Earnings before interest, tax 462.6 388.1 19.2% 535.3 509.0 5.2% and Depreciation (EBITDA) EBITDA Margin (%) 9
Slide 6: Key Balance Sheet Data – Consolidated financials
Key Balance Sheet Data – Consolidated financials Particulars March 31, 2020 March 31, 2019 Net Working Capital Rs. Crore 493.3 449.0 (Ex-cash and equivalents) Net Working Capital days Days 26 28 Total Debt Rs. Crore 630.3 395.3 Net Debt Rs. Crore 581.6 370.2 Equity (ex- minority interest) Rs. Crore
Slide 7: COVID-19 Impact
COVID-19 IMPACT 6 I Godrej Agrovet
Slide 8: COVID-19 - Impact on 4QFY20 performance
COVID-19- Impact on 4QFY20 performance • COVID-19 pandemic is the toughest situation in years • In February 2020, false rumour of linking COVID-19 infection to consumption of poultry and related products impacted the industry Demand and prices of poultry and its products declined Broiler and lay
Slide 9: GAVL well-positioned to emerge stronger in current unprecedented situation
GAVL in well-positioned to emerge stronger in current unprecedented situation • GAVL’s businesses are in agriculture sector, which is more resilient • Safety of employees and business partners is our key priority Strict health and safety protocols deployed across all businesses and locations • Str
Slide 10: Segment-wise Performance Update
SEGMENT-WISE PERFORMANCE UPDATE 9 I Godrej Agrovet
Slide 11: Animal Feed
ANIMAL FEED Leading compound feed play across Cattle, Broiler, Layer, Fish and Shrimp feed in India Particulars 4Q FY20 4Q FY19 Growth FY20 FY19 Growth Sales Volume (tons) 2,94,215 3,31,806 (11.3%) 13,00,838 12,64,510 2.9% Segment Revenue (Cr) 881.0 882.1 (0.1%) 3,717.7 3,096.8 20.1% Segment Result
Slide 12: Oil Palm Business
OIL PALM BUSINESS Largest domestic producer of Crude Palm oil and Palm Kernel Oil Particulars 4QFY20 4QFY19 Growth FY20 FY19 Growth Segment Revenue (Cr) 66.5 63.4 4.9% 673.5 679.3 (0.9%) Segment Result (Cr) 4.3 (0.1) NA 89.3 113.4 (21.2%) Segment Margin (%) 6.5% (0.2%) 13.3% 16.7% • Increase in crud
Slide 13: Crop Protection Business
CROP PROTECTION BUSINESS Agrochemical products produced cater to the entire crop lifecycles Particulars 4QFY20 4QFY19 Growth FY20 FY19 Growth Segment Revenue (Cr) 67.0 45.2 48.1% 567.7 549.4 3.3% Segment Result (Cr) 5.9 8.9 (33.9%) 153.8 160.1 (3.9%) Segment Margin (%) 8.8% 19.7% 27.1% 29.1% • Durin
Slide 14: Astec LifeSciences
ASTEC LIFESCIENCES Manufactures a wide range of agrochemical active ingredients and pharmaceutical intermediates Particulars 4QFY20 4QFY19 Growth FY20 FY19 Growth Revenue (Cr) 180.5 133.8 35.0% 522.6 430.9 21.3% EBITDA (Cr) 47.9 28.8 66.2% 97.1 87.6 10.8% EBITDA Margin (%) 26.5% 21.6% 18.6% 20.3% •
Slide 15: Creamline Dairy
CREAMLINE DAIRY Particulars 4QFY20 4QFY19 Growth FY20 FY19 Growth Revenue (Cr) 280.8 267.4 5.0% 1,193.0 1,157.8 3.0% EBITDA (Cr) 2.1 12.6 (83.3%) 32.3 42.7 (24.4%) EBITDA Margin (%) 0.7% 4.7% 2.7% 3.7% • Revenue growth was modest for 4QFY20 and FY20 as milk sales have declined in current year; howev
Slide 16: Godrej Tyson Foods Limited and ACI Godrej Agrovet Bangladesh
GODREJ TYSON FOODS LIMITED Particulars 4QFY20 4QFY19 Growth FY20 FY19 Growth Revenue (Cr) 113.9 120.1 (5.1%) 515.4 486.7 5.9% EBITDA (Cr) (33.5) 3.9 NA (47.6) 24.2 (297.0%) • Performance of the current quarter was adversely impacted by false rumours of linking COVID-19 to poultry; resulting in sharp
Slide 17: GAVL Shareholding Pattern
GAVL SHAREHOLDING PATTERN Shareholding pattern as on Major Investors March 31, 2020 Others , 9.7% • Temasek DII, 4.9% • Aberdeen • J P Morgan FII, 15.3% • Vanguard • Kotak MF • ICICI Prudential MF Promoters , 70.1% • Bajaj Holdings • Tata MF • LIC India 16 I Godrej Agrovet
Slide 18: Contact Us
CONTACT US To know more, visit us at: www.godrejagrovet.com S Varadaraj Chhavi Agarwal Email: s.varadaraj@godrejagrovet.com Email: chhavi.agarwal@godrejagrovet.com gavlinvestors@godrejagrovet.com gavlinvestors@godrejagrovet.com 17 I Godrej Agrovet
Slide 19: Disclaimer
DISCLAIMER Some of the statements in this communication may be forward looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied. Important developments that could affect the Company’s operations include change
Slide 20: Thank You for Your Time and Consideration
THANK YOU FOR YOUR TIME AND CONSIDERATION 19 I Godrej Agrovet